Monthly Archives: January 2017
The risks of brain damage after hyperthermia
The groundwater quality assessment of Fars province, Iran
MRI with GBCAs – Practical help to ensure patient safety
Malayeri et al writes: “At present, there is no evidence suggesting that gadolinium deposition in the brain alters neurologic function”. Where is the evidence for this statement? Free gadolinium is highly toxic. Even though no clinical implications
Inflammatory bowel disease (IBD) 2017: sorting out calls for inflammation
Targeted nanoparticles for molecular imaging
Eat your carrots – otherwise your risk of getting Alzheimer’s might increase!
Teasing apart the roles that oncogenic miRNAs play in breast cancer
Oncogenic miRNA and breast cancer Since the early 2000’s, the field of RNA has been contributing to major discoveries in cancer research. McroRNAs are small RNA molecules (miRNA), inhibit the messenger RNAs that produce our proteins. Normally,
EGCg-AuNPs Nanotherapeutics – as an alternative Green Nanotechnology approach for treating cardiovascular diseases
Levosimendan to reduce mortality in cardiac surgery (CHEETAH trial)
Over the past decade, there was a significant decline of mortality after cardiac-surgery. Although the average perioperative mortality for elective procedures currently is 1% to 2%, the rate of major complications remains high. Low-cardiac-output syndrome (LCOS, a
Cellular migration required for testis development
A multistep virtual screening approach to identify proteasome inhibitors
Could low albumin be a marker of an undiagnosed cancer?
Cancer is an increasingly common problem that affects one-in-two British people over the course of their lifetime. Survival rates are getting better with increased awareness, better tests and more effective treatments, but the UK still lags behind
How to characterize best the genetic content of small supernumerary marker chromosomes
High-performance polymer solar cells via Al-doped ZnO cathode interlayer
Alcohol and prostate cancer risk
In a large follow-up study, we found that heavy regular alcohol consumption and binge drinking during midlife were associated with a significantly increased risk of prostate cancer risk. Specifically, men who were heavy drinkers (>14 drinks/week) were
Patterns of mutation in cancer genes
Kinase inhibitors and new treatments for asthma and COPD
Do we hallucinate when we sleep?
By definition, hallucinations occur only when we are fully awake state. Yet the similarities to experiences that occur during the transition between sleep and wakefulness; dreams; and incubus phenomena have been known for a long time. In